Secretive Project Prometheus takes VC Bob Nelsen beyond just health care - statnews.com

1/14/2026

Vizgen Raises $48M With Support From ARCH, M Ventures, and Northpond - citybiz

1/8/2026

An Arch-backed biotech raises $53M to fight neurodegeneration - biopharmadive.com

12/4/2025

SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire

12/4/2025

Arch Venture Partners, L.P. Stock Portfolio - Intellectia AI

11/18/2025

Even Bigger Venture Bucks For Obesity Therapies As Metsera Sells For Up To $10B - Crunchbase News

11/12/2025

Ollin Biosciences Launches with Mission to Accelerate Best-in-class Therapies in Ophthalmology - BioSpace

9/18/2025

A family affair: Langers team up to invest in intersection of technology, biology - FirstWord Pharma

9/18/2025

Moderna co-founder collects $77.5m for T.Rx Capital - venturecapitaljournal.com

9/18/2025

9 Chicagoland firms named among Time's top venture capital firms of 2025 - The Business Journals

8/26/2025

Biotech VC raises $200M to focus on Japan’s ‘untapped source’ of innovation - Fierce Biotech

7/2/2025

AN Venture Partners Announces Final Close of $200M Fund I - Business Wire

7/2/2025

Arch's Keith Crandell talks Chicago, biotech - Axios

6/20/2025